NEW STUDY. A new blood test that can track and follow the neurodegeneration in Alzheimer’s disease – and exclude other dementias. That is an innovation now presented by researchers at the University of Gothenburg, together with colleagues in Italy and USA. In recent years, a lot of effort has been put on developing biomarkers in blood that could potentially help to diagnose and monitor Alzheimer’s disease (AD). Tau – one…
Optimal blood tests for development of new therapies of Alzheimer’s disease
NEW STUDY. A new study have identified which blood tests are best at detecting Alzheimer’s disease during the earliest stages, and another blood test that is optimal for detecting relevant treatment effects. These findings will speed up the development of new therapies that can slow down the disease progression. The Swedish study lead by Professor Oskar Hanssson, Lund University, and Professor Kaj Blennow, University of Gothenburg, looked at several newly…
New method can shed light on Alzheimer’s in individuals with Down syndrome
GRANT. Thanks to advances in research, individuals with Down syndrome are living longer, and their quality of life has improved. However, up to 90 percent of those with Down syndrome develop Alzheimer’s disease. Researcher Laia Montoliu-Gaya is creating a method that can increase understanding of how Alzheimer’s develops in this group. Individuals with Down syndrome, also known as trisomy 21, have an extra copy of chromosome 21. The APP gene,…
Towards improved diagnostics for several types of dementia
GRANT. Twenty years of research have culminated in blood tests that can be used for clinical diagnosis of Alzheimer’s disease. Henrik Zetterberg, professor of neurochemistry, has just been awarded the European Research Council’s prestigious Advanced Grant to establish similar markers for other forms of dementia. Long-term research into clinical neurochemistry at the University of Gothenburg has resulted in three well-established cerebrospinal fluid markers that are used around the world to…
New studies support blood test for early detection of Alzheimer’s disease
NEW STUDIES. In three recent publications in Molecular Psychiatry, Brain and JAMA Neurology researchers from the University of Gothenburg provide convincing evidence that an in-house developed blood test for Alzheimer’s disease can detect the disease early and track its course, which has major implications for a potential use in clinical practice and treatment trials. “This is an extremely dynamic research field right now, thanks to the technological development and seminal scientific progress in the past…